Preliminary studies suggest conolidine may possibly inhibit specific ion channels, decreasing neuronal excitability and restricting soreness indicators. This mechanism is especially relevant in neuropathic ache, the place abnormal signaling causes persistent soreness. In addition, conolidine seems to affect G protein-coupled receptor (GPCR) pathway